Acquisition in Spain Consistent implementation of growth strategy Active player of industry consolidation ots-CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Duisburg, 5 July 2006 - Today, Klöckner & Co has entered into an agreement for the acquisition of Aesga Catalunya S.A. (Aesga Catalunya) and affiliated Aesgasa Aceros Especiales y Suministros ...
Ludwigshafen, Germany (ots/PRNewswire) - - BASF CEO Hambrecht: 'We started the integration process.' BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN) today announced the successful completion of its acquisition of Engelhard Corporation (NYSE: EC). "Together with the Engelhard team we have started the integration process in which our customers continue to be the key priority," ...
Ingelheim, Germany (ots/PRNewswire) - - Not for Distribution or Publication in the United States New omnibus data from the largest global survey due to be published, conducted on the epidemiology of constipation, were presented today at the Digestive Disease Week congress in Los Angeles. The survey, sponsored by Boehringer Ingelheim, offers new insights into the incidence of constipation and shows that ...
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Professional and Consumer Journalists - Not for Distribution to USA Media - Survey Shows 25% of World's Population Suffer From Common and Distressing Ailment That can be Effectively Treated New data presented at the premier international gastroenterology congress Digestive Disease Week (DDW) 2006 ...
Ingelheim, Germany (ots/PRNewswire) - - For Non-US Healthcare Professional Media Boehringer Ingelheim announced today that that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of Sifrol(R) / Mirapexin(R) ...
Ludwigshafen, Germany (ots) - * BASF Intends To Offer US$37.00 Per Share For a Total of US$4.9 Billion * Acquisition Would Make BASF a Leading Provider in the Global Catalyst Business BASF Aktiengesellschaft (Frankfurt: BAS, NYSE: BF [ADR], LSE: BFA, SWX: AN), the world's leading chemical company, has made an all-cash proposal to acquire all outstanding shares of common stock of Engelhard ...
Dublin, Ireland, November 21 (ots/PRNewswire) - - New hope for HIV/AIDS patients: APTIVUS(R) outperforms several commonly prescribed drugs in the protease inhibitor (PI) class DUBLIN, Ireland, November 21 /PRNewswire/ -- - Experts Emphasize Need for Effective Therapy in Response to Increased Prevalence of HIV/AIDS throughout Europe At the 10th European AIDS Clinical Society (EACS) conference, experts ...
Dublin, Ireland, November 21 (ots/PRNewswire) - - Additional Data Provide Further Guidance on Maximizing Treatment Response with APTIVUS(R) New data presented at the 10th European AIDS Conference (EACS) in Dublin demonstrate that through 48 weeks, APTIVUS(R) (tipranavir) provides a convincing and durable benefit, achieving and maintaining a superior treatment response in patients with resistant HIV.(1) ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 15.11.2005 ElringKlinger achieves 4 percent growth in sales revenues and 7 percent growth in net earnings in the first nine months Dettingen/Erms (Germany), November 15, 2005 --- The ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 12.10.2005 - Production target of 500,000 boe/d until 2010 - Further expansion of Refining and Marketing business in EU accession area - Expand gas marketing activities to 20 bcm of gas until ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 03.08.2005 Ad hoc Press Release Cologne, 3 August 2005 - At its meeting on 03.08.2005 the Supervisory Board of DocCheck(R) AG has decided to make some changes at Board level. A new appointment ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 03.08.2005 Cologne, 3 August 2005 - DocCheck(R) AG, Cologne, (ISIN DE0005471007 // Symbol 547100), previously antwerpes ag, has achieved sales totalling 2.9 million euro in the 2nd quarter of ...
Rio De Janeiro, Brazil and Ingelheim, Germany (ots/PRNewswire) - - New Data Support its Use as Powerful Treatment Against HIV Drug Resistance RIO DE JANEIRO, Brazil and INGELHEIM, Germany, July 28 /PRNewswire/ -- Boehringer Ingelheim announced today that the CHMP (Committee for Medicinal Products for Human Use) in London has issued a positive opinion for tipranavir, a non-peptidic protease inhibitor, to ...
Ridgefield, Connecticut (ots/PRNewswire) - - The Following Press Release Was Issued By Our U.S. Affiliate Boehringer Ingelheim Pharmaceuticals, Inc. in The United States on June 23, 2005 Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Aptivus(R) (tipranavir) ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 17.05.2005 Cuxhaven, 17 May 2005 - The wind farm project company Plambeck Neue Energien AG has sold its 80 percent shareholding in the French windfarm project company, Ventura SA, to the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 01.03.2005 Fujitsu Limited and Software AG today announced their intent to jointly develop, market and sell an offering that will help customers improve business processes and increase ...
INGELHEIM, Germany,, February 28 (ots/PRNewswire) - - Tipranavir/r More Effective Than Lopinavir/r in Large-Scale Studies of Treatment-Experienced HIV-Positive Patients New data from multiple analyses presented last week at the 12th Conference on Retroviruses and Opportunistic Infections support the efficacy of the investigational non-peptidic protease ...
1&1 Mail & Media Applications SE
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 27.01.2005 WEB.DE AG (ISIN DE 000 529 650 3), subdivided into its business segments Portal and Web-Telecommunications, has released preliminary figures for Q4/2004 and fiscal year 2004 which ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Software AG has appointed Dr. Peter Kürpick to the Board of Directors with responsibility for the "XML Business Integration" division, to further expand this strategic business unit. The ...
Glasgow, Scotland, November 18 (ots/PRNewswire) - - RESIST-2 Data Demonstrate Efficacy in Treatment-Experienced Patient Population New tipranavir pivotal Phase III data show that a statistically significant higher percentage of treatment-experienced HIV-positive patients taking tipranavir therapy achieved treatment response versus those taking other ...
Washington, November 1 (ots/PRNewswire) - New data from a pivotal Phase 3 study (RESIST-1) demonstrate that a statistically significant greater percentage of HIV-positive patients taking a tipranavir-based regimen achieved a treatment response versus those taking a regimen containing one of several marketed protease inhibitors (PIs). Treatment response in this study ...
Ingelheim, Germany (ots/PRNewswire) - Boehringer Ingelheim today announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for tipranavir. Simultaneously the documentation was submitted to the FDA. Tipranavir is a non-peptidic protease inhibitor (NPPI) for ...
1&1 Mail & Media Applications SE
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. WEB.DE AG reports a very positive business development for the first nine months of fiscal 2004 (Q1-Q3/2004). During the reporting period WEB.DE AG raised revenues within the Group by 7.4 ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Software AG CEO, Karl-Heinz Streibich, is focusing the company on two strategic business lines. Product development for Enterprise Transaction Systems (Adabas and Natural) and XML Integration ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. - Acquisition of 51% stake in Petrom through a combination of a direct purchase of 33.34% and a simultaneous capital increase in Petrom - Group oil and gas reserves more than tripled: 1 billion ...
1&1 Mail & Media Applications SE
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. WEB.DE AG once again reports on a very positive business development in the first half of fiscal 2004 (H1/2004): In second quarter of fiscal 2004 (Q2/2004) revenues rose to more than EUR 10 ...
Munich (ots) - cross-reference: photos are available at: http://www.naeurope.co.uk/en/story.htx?nr=300002620 Alain Pompidou took up office today as President of the European Patent Office (EPO). The 62-year old Frenchman succeeds a German, Ingo Kober, who, having held this post since 1996, is now going into retirement. Elected in December 2003 by the ...
Freudenberg & Co. Kommanditgesellschaft
Weinheim (ots) - At the beginning of 2004, the Freudenberg Group completed a far-reaching reorientation of its portfolio, according to the report presented by Dr. Peter Bettermann, Speaker of the Management Board of Freudenberg & Co., at this year's annual press conference of the Group in Weinheim. Over the past five years, the Group has disposed of companies with annual sales totaling some 400 million Euro. The Group ...
1&1 Mail & Media Applications SE
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. WEB.DE AG reports a continuing positive business development in its review of the first quarter of fiscal 2004. In Q1/2004 year-on-year revenues increased by EUR +2.2 million or 30% to EUR 9.5 ...
Heidelberg (ots) - Business Intelligence in Practice: A Host of Software Applications at the SAS Stand - SAS demonstrates solutions for corporate governance/financial intelligence, customer relationship management and IT cost management The motto this year for SAS at CeBIT is "Focus Business Intelligence": The company will be presenting its current business intelligence portfolio in Hall 4, ...
